Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile, Zoom Video Communications and Zynga.
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Thursday's top analyst upgrades and downgrades included Apple, AT&T, Avis Budget, Baidu, Baker Hughes, Biogen, Chipotle Mexican Grill, Kinder Morgan, Netflix, Shopify and Ulta Beauty.
Biogen reported better than expected first-quarter financial results before the markets opened on Wednesday.
Chris Lange 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including Amazon, Tesla, Netflix and Starbucks.
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Many of the larger biotechnology and pharmaceutical companies have changed strategies from making acquisitions of speculative biotech outfits. In many cases it is far cheaper to just partner up with these smaller…
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems and Virgin Galactic.
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Tuesday's top analyst upgrades, downgrades and initiations included Aurora Cannabis, Biogen, EverQuote, Micron Technology, Nio, Nvidia, Palo Alto Networks, Tandem Diabetes Care, Tesla and Wix.com.
Investors are not used to hearing is the word "biotech" used in the same sentence as anything to do with Warren Buffett and Berkshire Hathaway. Yet the portfolio managers have purchased shares…
